DocGo Inc. (NASDAQ:DCGO – Get Free Report) has been assigned an average rating of “Hold” from the five brokerages that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and one has given a buy recommendation to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $2.25.
Several brokerages have issued reports on DCGO. Canaccord Genuity Group dropped their target price on DocGo from $1.60 to $1.50 and set a “buy” rating on the stock in a research report on Wednesday, November 12th. Weiss Ratings reissued a “sell (d-)” rating on shares of DocGo in a research report on Monday, December 29th.
View Our Latest Stock Report on DocGo
Institutional Trading of DocGo
DocGo Stock Up 0.0%
Shares of DCGO stock opened at $0.67 on Tuesday. The firm has a market cap of $65.75 million, a price-to-earnings ratio of -1.29 and a beta of 0.95. DocGo has a 52-week low of $0.63 and a 52-week high of $3.08. The company’s 50 day moving average is $0.80 and its 200 day moving average is $1.06.
DocGo Company Profile
DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.
In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.
See Also
- Five stocks we like better than DocGo
- The Market Just Split in Two (URGENT)
- Buy this Gold Stock Before May 15th, 2026
- J.P. Morgan is betting on this coin
- Central banks just did something they haven’t done since 1967
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
